| SEGMENT AND RELATED INFORMATION |
NOTE 9 - SEGMENT AND RELATED INFORMATION
The Company operates in two reportable segments -
manufacturing and the service of medical equipment and management of diagnostic imaging centers. The accounting policies of the segments
are the same as those described in the summary of significant accounting policies as disclosed in the Company’s 10-K as of June
30, 2025. All inter segment sales are market-based. The Company evaluates performance based on income or loss from operations.
Our chief operating decision maker (“CODM”),
who is also our CEO, evaluates the financial performance of our segments based upon their respective revenue and segmented internal profit
and loss statements prepared on a basis not consistent with GAAP. The CODM considers actual to budget and current year actual to prior
year actual for revenue and other profit and loss measures on a monthly basis for evaluating performance of each segment and making decisions
about allocating capital and other resources to each segment.
Summarized financial information concerning the Company’s
reportable segments is shown in the following table:
| Schedule
of summarized segment financial information |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Manufacturing and Servicing of Medical |
|
Management of Diagnostic Imaging |
|
|
| Three months ended March 31, 2026 |
|
Equipment |
|
Centers |
|
Totals |
| Net revenues from external customers |
|
$ |
2,282 |
|
|
$ |
24,190 |
|
|
$ |
26,472 |
|
| Cost of Sales |
|
|
|
|
|
|
|
|
|
|
|
|
| Salaries and wages |
|
|
909 |
|
|
|
5,465 |
|
|
|
6,374 |
|
| Rent expense |
|
|
— |
|
|
|
1,233 |
|
|
|
1,233 |
|
| Other Cost of sales expenses** |
|
|
538 |
|
|
|
7,086 |
|
|
|
7,624 |
|
| Total Cost of sales |
|
$ |
1,447 |
|
|
$ |
13,784 |
|
|
$ |
15,231 |
|
| Research and development |
|
|
|
|
|
|
|
|
|
|
|
|
| Salaries and wages |
|
|
194 |
|
|
|
— |
|
|
|
194 |
|
| Other research and development costs** |
|
|
230 |
|
|
|
— |
|
|
|
230 |
|
| Total Research and development costs |
|
$ |
424 |
|
|
$ |
— |
|
|
$ |
424 |
|
| Selling, general and administrative expenses |
|
|
|
|
|
|
|
|
|
|
|
|
| Salaries and wages |
|
|
443 |
|
|
|
3,145 |
|
|
|
3,588 |
|
| Rent expense |
|
|
313 |
|
|
|
18 |
|
|
|
331 |
|
| Other selling, general and administrative expenses** |
|
|
2,323 |
|
|
|
2,131 |
|
|
|
4,454 |
|
| Total Selling, general and administrative expenses |
|
$ |
3,079 |
|
|
$ |
5,294 |
|
|
$ |
8,373 |
|
| Total costs and expenses |
|
$ |
4,950 |
|
|
$ |
19,078 |
|
|
$ |
24,028 |
|
| (Loss) Income from operations |
|
$ |
(2,668 |
) |
|
$ |
5,112 |
|
|
$ |
2,444 |
|
| Investment income |
|
|
20 |
|
|
|
343 |
|
|
|
363 |
|
| Other income |
|
|
16 |
|
|
|
(3 |
) |
|
|
13 |
|
| (Loss) Income before provision for income taxes |
|
$ |
(2,632 |
) |
|
$ |
5,452 |
|
|
$ |
2,820 |
|
| Provision for income taxes |
|
|
(379 |
) |
|
|
(113 |
) |
|
|
(492 |
) |
| Net (Loss) income |
|
$ |
(2,253 |
) |
|
$ |
5,339 |
|
|
$ |
2,328 |
|
| Intersegment net revenues * |
|
|
307 |
|
|
|
— |
|
|
|
307 |
|
| Depreciation and amortization |
|
|
55 |
|
|
|
1,051 |
|
|
|
1,106 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Manufacturing and Servicing of Medical |
|
Management of Diagnostic Imaging |
|
|
| Three months ended March 31, 2025 |
|
Equipment |
|
Centers |
|
Totals |
| Net revenues from external customers |
|
$ |
2,395 |
|
|
$ |
24,770 |
|
|
$ |
27,165 |
|
| Cost of Sales |
|
|
|
|
|
|
|
|
|
|
|
|
| Salaries and wages |
|
|
924 |
|
|
|
4,848 |
|
|
|
5,772 |
|
| Rent expense |
|
|
— |
|
|
|
1,224 |
|
|
|
1,224 |
|
| Other Cost of sales expenses** |
|
|
635 |
|
|
|
7,440 |
|
|
|
8,075 |
|
| Total Cost of sales |
|
$ |
1,559 |
|
|
$ |
13,512 |
|
|
$ |
15,071 |
|
| Research and development |
|
|
|
|
|
|
|
|
|
|
|
|
| Salaries and wages |
|
|
192 |
|
|
|
— |
|
|
|
192 |
|
| Other research and development costs** |
|
|
249 |
|
|
|
— |
|
|
|
249 |
|
| Total Research and development costs |
|
$ |
441 |
|
|
$ |
— |
|
|
$ |
441 |
|
| Selling, general and administrative expenses |
|
|
|
|
|
|
|
|
|
|
|
|
| Salaries and wages |
|
|
668 |
|
|
|
2,905 |
|
|
|
3,573 |
|
| Rent expense |
|
|
313 |
|
|
|
22 |
|
|
|
335 |
|
| Other selling, general and administrative expenses** |
|
|
787 |
|
|
|
3,296 |
|
|
|
4,083 |
|
| Total Selling, general and administrative expenses |
|
$ |
1,768 |
|
|
$ |
6,223 |
|
|
$ |
7,991 |
|
| Total costs and expenses |
|
$ |
3,768 |
|
|
$ |
19,735 |
|
|
$ |
23,503 |
|
| (Loss) Income from operations |
|
$ |
(1,373 |
) |
|
$ |
5,035 |
|
|
$ |
3,662 |
|
| Investment income |
|
|
25 |
|
|
|
438 |
|
|
|
463 |
|
| Other income (expense) |
|
|
12 |
|
|
|
(7 |
) |
|
|
5 |
|
| (Loss) Income before provision for income taxes |
|
$ |
(1,336 |
) |
|
$ |
5,466 |
|
|
$ |
4,130 |
|
| Provision for income taxes |
|
|
(902 |
) |
|
|
(104 |
) |
|
|
(1,006 |
) |
| Net (Loss) income |
|
$ |
(2,238 |
) |
|
$ |
5,362 |
|
|
$ |
3,124 |
|
| Intersegment net revenues * |
|
|
294 |
|
|
|
— |
|
|
|
294 |
|
| Depreciation and amortization |
|
|
52 |
|
|
|
1,186 |
|
|
|
1,238 |
|
*Amounts
eliminated in consolidation
**
Other segment costs include supplies, professional fees, marketing expenses, repairs and maintenance and other operational costs.
FONAR CORPORATION AND SUBSIDIARIES
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Manufacturing and Servicing of Medical |
|
Management of Diagnostic Imaging |
|
|
| Nine months ended March 31, 2026 |
|
Equipment |
|
Centers |
|
Totals |
| Net revenues from external customers |
|
$ |
7,191 |
|
|
$ |
70,871 |
|
|
$ |
78,062 |
|
| Cost of Sales |
|
|
|
|
|
|
|
|
|
|
|
|
| Salaries and wages |
|
|
2,808 |
|
|
|
15,461 |
|
|
|
18,269 |
|
| Rent expense |
|
|
— |
|
|
|
3,778 |
|
|
|
3,778 |
|
| Other Cost of sales expenses** |
|
|
1,468 |
|
|
|
23,165 |
|
|
|
24,633 |
|
| Total Cost of sales |
|
$ |
4,276 |
|
|
$ |
42,404 |
|
|
$ |
46,680 |
|
| Research and development |
|
|
|
|
|
|
|
|
|
|
|
|
| Salaries and wages |
|
|
610 |
|
|
|
— |
|
|
|
610 |
|
| Other research and development costs** |
|
|
709 |
|
|
|
— |
|
|
|
709 |
|
| Total Research and development costs |
|
$ |
1,319 |
|
|
$ |
— |
|
|
$ |
1,319 |
|
| Selling, general and administrative expenses |
|
|
|
|
|
|
|
|
|
|
|
|
| Salaries and wages |
|
|
1,492 |
|
|
|
8,600 |
|
|
|
10,092 |
|
| Rent expense |
|
|
939 |
|
|
|
54 |
|
|
|
993 |
|
| Other selling, general and administrative expenses** |
|
|
4,507 |
|
|
|
5,833 |
|
|
|
10,340 |
|
| Total Selling, general and administrative expenses |
|
$ |
6,938 |
|
|
$ |
14,487 |
|
|
$ |
21,425 |
|
| Total costs and expenses |
|
$ |
12,533 |
|
|
$ |
56,891 |
|
|
$ |
69,424 |
|
| (Loss) Income from operations |
|
$ |
(5,342 |
) |
|
$ |
13,980 |
|
|
$ |
8,638 |
|
| Investment income |
|
|
61 |
|
|
|
1,207 |
|
|
|
1,268 |
|
| Other income (expense) |
|
|
47 |
|
|
|
(9 |
) |
|
|
38 |
|
| (Loss) Income before provision for income taxes |
|
$ |
(5,234 |
) |
|
$ |
15,178 |
|
|
$ |
9,944 |
|
| Provision for income taxes |
|
|
(2,163 |
) |
|
|
(244 |
) |
|
|
(2,407 |
) |
| Net (Loss) income |
|
$ |
(7,397 |
) |
|
$ |
14,934 |
|
|
$ |
7,537 |
|
| Intersegment net revenues * |
|
|
919 |
|
|
|
— |
|
|
|
919 |
|
| Depreciation and amortization |
|
|
149 |
|
|
|
3,298 |
|
|
|
3,447 |
|
| Total identifiable assets |
|
$ |
34,007 |
|
|
$ |
185,215 |
|
|
$ |
219,222 |
|
* Amounts
eliminated in consolidation
**
Other segment costs include supplies, professional fees, marketing expenses, repairs and maintenance and other operational costs.
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Manufacturing and Servicing of Medical |
|
Management of Diagnostic Imaging |
|
|
| Nine months ended March 31, 2025 |
|
Equipment |
|
Centers |
|
Totals |
| Net revenues from external customers |
|
$ |
6,382 |
|
|
$ |
70,693 |
|
|
$ |
77,075 |
|
| Cost of Sales |
|
|
|
|
|
|
|
|
|
|
|
|
| Salaries and wages |
|
|
2,736 |
|
|
|
14,419 |
|
|
|
17,155 |
|
| Rent expense |
|
|
— |
|
|
|
3,601 |
|
|
|
3,601 |
|
| Other Cost of sales expenses** |
|
|
1,390 |
|
|
|
23,046 |
|
|
|
24,436 |
|
| Total Cost of sales |
|
$ |
4,126 |
|
|
$ |
41,066 |
|
|
$ |
45,192 |
|
| Research and development |
|
|
|
|
|
|
|
|
|
|
|
|
| Salaries and wages |
|
|
561 |
|
|
|
— |
|
|
|
561 |
|
| Other research and development costs** |
|
|
563 |
|
|
|
— |
|
|
|
563 |
|
| Total Research and development costs |
|
$ |
1,124 |
|
|
$ |
— |
|
|
$ |
1,124 |
|
| Selling, general and administrative expenses |
|
|
|
|
|
|
|
|
|
|
|
|
| Salaries and wages |
|
|
1,701 |
|
|
|
8,216 |
|
|
|
9,917 |
|
| Rent expense |
|
|
939 |
|
|
|
68 |
|
|
|
1,007 |
|
| Other selling, general and administrative expenses** |
|
|
2,200 |
|
|
|
6,931 |
|
|
|
9,131 |
|
| Total Selling, general and administrative expenses |
|
$ |
4,840 |
|
|
$ |
15,215 |
|
|
$ |
20,055 |
|
| Total costs and expenses |
|
$ |
10,090 |
|
|
$ |
56,281 |
|
|
$ |
66,371 |
|
| (Loss) Income from operations |
|
$ |
(3,708 |
) |
|
$ |
14,412 |
|
|
$ |
10,704 |
|
| Investment income |
|
|
83 |
|
|
|
1,543 |
|
|
|
1,626 |
|
| Other income (expense) |
|
|
38 |
|
|
|
(21 |
) |
|
|
17 |
|
| (Loss) Income before provision for income taxes |
|
$ |
(3,587 |
) |
|
$ |
15,934 |
|
|
$ |
12,347 |
|
| Provision for income taxes |
|
|
(2,796 |
) |
|
|
(222 |
) |
|
|
(3,018 |
) |
| Net (Loss) income |
|
$ |
(6,383 |
) |
|
$ |
15,712 |
|
|
$ |
9,329 |
|
| Intersegment net revenues * |
|
|
881 |
|
|
|
— |
|
|
|
881 |
|
| Depreciation and amortization |
|
|
157 |
|
|
|
2,184 |
|
|
|
2,341 |
|
| Total identifiable assets |
|
$ |
33,577 |
|
|
$ |
181,346 |
|
|
$ |
214,923 |
|
* Amounts eliminated in consolidation
** Other segment costs include supplies, professional
fees, marketing expenses, repairs and maintenance and other operational costs.
|